Primary Job Title Chief Strategy Officer (CSO) Primary Organization 
CardioDx
Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male
Investor Type
LinkedIn View on LinkedIn
David founded CardioDx in 2004, and served as the President and Chief Executive Officer of the company until 2016. David drove the successful commercialization of the Corus CAD blood test with over 250,000 patients having received and benefited from the Corus CAD test. Prior to launching CardioDx, David was a Venture Partner at Texas Pacific Group
Ventures and was also the interim Chief Executive Officer and Director of CareDx (formerly XDx, Inc.). Previously, he was the Founder, President, and Chief Executive Officer of iScribe, a healthcare technology company acquired by AdvancePCS (now Caremark). Prior to iScribe, David was President of Oncology Therapeutics Network (OTN), which was acquired by Bristol-Myers Squibb in 1996. Prior to OTN, he was with Cole Gilburne Fund, an early-stage, technology-focused venture capital firm. David continues to serve as a Director on both public and private Boards.
